Affiliation(s): 1Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
2Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou 310058, China
3Zhejiang Key Laboratory of Maternal and Infant Health, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
Abstract: Hydatidiform mole (HM) is a gestational trophoblastic disease causing abnormal trophoblastic proliferation and pregnancy loss, often accompanied by a significant psychological burden. To elucidate the molecular basis and recurrence mechanisms of HM, we performed high-throughput proteomic profiling of FFPE villous tissues from 8 sporadic HM cases (HMS), 6 primary HM from recurrent cases (HMRP), 13 recurrent HM cases (HMR), and 8 normal villus cases (NV). A total of 2,959 differentially expressed proteins were identified, revealing immune dysregulation and metabolic reprogramming in HM. CD55 and ITGAM emerged as central network hubs of HM, while the recurrence-associated signature indicated altered extracellular matrix composition and the suppression of key transcriptional regulators (YAP1, STK3, POU2F1). Proteomic trajectory analysis from HMS to HMR highlighted the persistent downregulation of neutrophil degranulation and the upregulation of the immune checkpoint CD276 (B7-H3). These findings delineate the proteomic evolution and immune landscape of HM, offering molecular insights for recurrence risk assessment and potential targeted therapies for improved clinical management.
Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article
Reference
Open peer comments: Debate/Discuss/Question/Opinion
Open peer comments: Debate/Discuss/Question/Opinion
<1>